Bloomberg Billionaires Index

View profiles for each of the world’s 500 richest people, see the biggest movers, and compare fortunes or track returns.

# 260 Li Ge $7.79B

Random fact: Company has been dubbed the Huawei of the pharmaceutical industry.

Overview

Li is the chairman and chief executive officer of WuXi AppTec, a pharmaceutical outsourcing provider and manufacturer of medical products. The Shanghai-based company has about 28,000 employees and is involved in drug design and testing. It had revenue of 16.5 billion yuan ($2.4 billion) in 2020. Li is a U.S. citizen.

As of :
Last change +$944k ( +0.0%)
YTD change -$890M ( -10.3%)
Biggest asset 603259 CH Equity
Country / Region United States
Age 55
Industry Health Care
View net worth over:   Max 1 year 1 quarter 1 month 1 week

Relative Value

Li Ge's net worth of $7.79B can buy ...

0
troy ounces of gold
0
barrels of crude oil

... and is equivalent to ...

0%
of the GDP of the United States
0%
of the total wealth of the 500 richest people in the world
0%
of the top 100 U.S. college endowments
0%
of the top 200 U.S. executives’ total awarded compensation
0%
of U.S. existing home sales
0
times the median U.S. household income

Latest News

Net Worth Summary

Cash
Private asset
Public asset
Misc. liabilities
Confidence rating:

The majority of Li's fortune is derived from WuXi AppTec, a pharmaceutical outsourcing provider and manufacturer of medical products. The Shanghai-based company has 28,000 employees and is involved in activities including drug design and testing, according to its website.

He owns a 9% stake in WuXi AppTec through two holding companies G&C VI and G&C V, according to the company's 2021 semi-annual report.

He also holds a 4% stake in WuXi Biologics through British Virgin Islands and Cayman Islands based holding companies, according to a July 23, 2021 Hong Kong stock exchange filing.

Yao Chi, a spokesperson for the company, declined to comment on the net worth calculation.

Biography

Birthdate: 1/1/1967
Family: Married, No children
Education: Columbia University, Columbia University, Peking University

Li was born in January 1967. He graduated from Peking University with a bachelor’s degree in chemistry in July 1989. Li obtained a Ph.D. degree in organic chemistry from Columbia University in the U.S. in February 1994, according to WuXi AppTec's 2018 prospectus.

In May 1993, Li was a founding scientist at U.S. biotechnology company Pharmacopeia Inc. Li left the company in 2000 and started WuXi PharmaTech in the same year.

His company began trading publicly in New York in 2008 before removing itself from the NYSE seven years later. It was listed in Shanghai and Hong Kong in 2018 under the new name WuXi AppTec.

Milestones
  • 2000 WuXi PharmaTech is registered in Wuxi, China.
  • 2007 WuXi PharmaTech begins trading in New York.
  • 2015 Wuxi PharmaTech is delisted from the New York Stock Exchange.
  • 2018 WuXi AppTec begins trading publicly in Shanghai and Hong Kong.